Revyve Secures €24m to Scale Yeast-Based Egg Alternatives

Dutch Food Tech Revyve Wins €24M to Bring Yeast Proteins to Scale

When Revyve, a Dutch food tech scale-up, announced it had secured €24 million in Series B funding, the news rippled through the alternative protein and ingredient innovation community. The raise, co-led by the ABN AMRO Sustainable Impact Fund and Invest-NL, with support from the Brabant Development Agency (BOM), pushes the company’s total funding past €40 million.Alternative Protein

Revyve secures €24m to scale yeast-based egg alternatives

Revyve has raised nearly €24 million in Series B financing to accelerate the rollout of its functional yeast proteins, designed to replace eggs and additives in mainstream food categories.

Revyve scaling up production by €24m financing - European Biotechnology Magazine

Wageningen-based food-tech scale-up Revyve has raised €24m in a Series B financing, bringing its total capital raised to more than €40 million. The company will use the proceeds to scale up its yeast-based egg replacement to the 1,600 t/a scale. The post Revyve scaling up production by €24m financing appeared first on European Biotechnology Magazine.